Midterm results of aortic valve replacement with cryopreserved homografts

Amaç: Çalışmada kriyoprezerve homogreftler ile kapak replasman sonuçlarının orta dönem sonuçları incelenmiştir. Hastalar ve Yöntemler: Kriyopreserve homogreft ile 40 olguda aort kapak replasmanı yapıldı. Endikasyonlar; 20 olguda aort kapak endokarditi, 6 olguda truncus arteriosus ve 14 olguda aort kapak tamir prosedürü sonrası reoperasyonlardı. Kapak çapları 10-27mm idi. Tüm olgularda kök replasman tekniği kullanıldı. Bulgular: Operasyon sonrası 30 günlük mortalite oranı %12,5'ti. Geç dönemde 4 olgu kaybedildi. Sadece 1 olguda mortalite kardiyak nedenlere bağlıydı. Toplam mortalite oranı %22,5'ti. 33 olgu ortalama 67±26 aylık süreçte izlendi. Endokardite bağlı aort anevrizması nedeni ile 2 olgu tekrar ameliyat edildi. Replasman sonrası transvalvular gradiyentlerde istatistiksel anlamlı düşüş gözlendi (p

Kriyopreserve homogreft ile aort kapak replasmanı orta dönem sonuçları

Objective: The aim of this study was to analyze the midterm clinical results of aortic valve replacement with cryopreserved homografts. Materials and Methods: Aortic valve replacement was performed in 40 patients with cryopreserved homograft. The indications were aortic valve endocarditis in 20 patients (50%), truncus arteriosus in 6 patients (15%), and re-stenosis or regurtitation after aortic valve reconstruction in 14 (35%) patients. The valve sizes ranged from 10 to 27mm. A full root replacement technique was used for homograft replacement in all patients. Results: The 30-day postoperative mortality rate was 12.5% (5 patients). There were four late deaths. Only one of them was related to cardiac events. Overall mortality was 22.5%. Thirty-three patients were followed up for 67±26 months. Two patients needed reoperation due to aortic aneurysm caused by endocarditis. The mean transvalvular gradient significantly decreased after valve replacement (p

___

  • 1. Bonow RO, Carabello B, De Leon AC. Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-588. [CrossRef]
  • 2. Westaby S, Amarasena N, Long V. Time-related hemodynamic changes after aortic replacement with the Freestyle stentless xenogaft. Ann Thorac Surg 1995;60:1633-9. [CrossRef]
  • 3. Hopkins RA. Cardiac Reconstructions with allograft valves. Springer-Werlag New York Inc 1989. [CrossRef]
  • 4. Dale J, Leveng O, Enge I. Long term results after aortic valve replacement with four different prostheses. Am Heart J 1980;99:155-62. [CrossRef]
  • 5. Horstkotte D, Korfer R, Seipel L. Late complications in patients with Bjork-Shiley and St. Jude medical heart valve replacement. Circulation 1983;68:175-84.
  • 6. Haykock D, Barrat-Boyes B, Macedo T. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thor Cardiovasc Surg 1992;103:130-9.
  • 7. Tuna IC, Orszulak TA, Schaff HV. Results of homograft aortic valve replacement for active endocarditis. Ann Thorac Surg 1990;49:619-24. [CrossRef]
  • 8. Kirklin JK, Pacifico AD, Kirklin JW. Surgical treatment of prosthetic valve endocarditis with aortic valve replacement. J Card Surg 1989;4:340-7. [CrossRef]
  • 9. Ross D. Allograft root replacement for prosthetic endocarditis. J Card Surg 1990;5:68-72. [CrossRef]
  • 10. Glezier JJ, Verwilghen J, Donalson RM. Treatment of complicated prosthetic aortic valve endocarditis with annular abscess formation by homograft aortic root replacement. J Am Coll Cardiol 1991;17:1177-82. [CrossRef]
  • 11. Donaldson RM, Ross DM. Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation 1984;70:178-81.
  • 12. Lau JK, Robles A. Cherian A, Ross DN. Surgical treatment of prosthetic endocarditis. Aortic root replacement using a homograft. J Thorac Cardiovasc Surg 1984;87:712-6.
  • 13. Maselli D, Pizio R, Bruno LP. Left ventricular mass reduction after aortic valve replacement homografts, stentless and stented valves. Ann Thorac Surg 1999;67:966-71. [CrossRef]
  • 14. McGiffin DC, O’Brien MF, Stafford EG. Long-term results of the viable cryopreserved allograft aortic valve. J Card Surg 1988; 3:289:96.
  • 15. Farina G. Cerasuolo F, DeLuca T. Biennial experience with aortic valve homografts prepared and preserved in our bank. G Ital Cardiol 1994;24:965-72.
  • 16. Grinda JM, Mainardi JL, D’Attellis N, Bricourt MO, Berrebi A, Fabiani JN, Deloche A. Cryopreserved aortic viable homograft for active aortic endocarditis. Ann Thorac Surg 2005;79:767-71. [CrossRef]
  • 17. Riberi A, Caus T, Mesana T, Goudard A, Mouly A, Habib G, Monties JR. Aortic valve or root replacement with cryopreserved homograft for active infectious endocarditis. Cardiovasc Surg 1997;5:579-83. [CrossRef]
  • 18. Niwaya K, Knott-Craig CJ, Santangelo K, Lane MM, Chandrasekaran K, Elkins RC. Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis. Ann Thorac Surg 1999;67:1603-8. [CrossRef]
  • 19. Yap C-H, Yii M. Factor’s influencing late allograft valve failure. Scand Cardiovasc J 2004;38:325-33. [CrossRef]
  • 20. Fooghsgaard S, Bruun N, Kjaergard H. Outcome of aortic homograft implantation in 24 cases of severe infective endocarditis. Scand J Infect Dis 2008;40:216-20. [CrossRef]
  • 21. Talwar S, Mohapatra R, Saxena A, Singh R, Kumar AS. Aortic homograft: A suitable substitute for aortic valve replacement. Ann Thorac Surg 2005;80:832-8. [CrossRef]
  • 22. Ng SK, O’Brien MF, Harrocks S, McLachlan GJ. Influence of patient age and implantation technique on the probability of rereplacement of the homograft aortic valve. J Heart Valve Dis 2002;11:217-23.
  • 23. Barratt-Boyes BG. Aortic allograft valve implantation: freehand or root replacement? J Card Surg 1994;9:196-7. [CrossRef]
  • 24. Willems TP, Takkenberg JJ, Steyerberg EW, Kleyburg-Linkers VE, Roelandt JR, Bos E, van Herwerden LA. Human tissue valves in aortic position: determinants of reoperation and valve regurgitation. Circulation 2001;103:1515-21. [CrossRef]
  • 25. Motomura N, Takamayo S. Indivations for and results of cryopreserved homograft valve replacement. Nippon Geka Gakkai Zasshi 2001;102:325-9.
  • 26. Prager RL, Ischer CL, Kong B. The Aortic Homograft. Evolution of Indications, techniques and results in 107 patients. Ann Thorac Surg 1997;64:659-64. [CrossRef]
  • 27. Choudhary SK, Talwar S, Kumar AS. Bentall operation with valved homograft conduit. Tex Heart Inst J 2000;27:366-8.
Balkan Medical Journal-Cover
  • ISSN: 2146-3123
  • Yayın Aralığı: 6
  • Başlangıç: 2015
  • Yayıncı: Galenos Yayınevi
Sayıdaki Diğer Makaleler

A case of escherichia coli endocarditis after hemorrhoidectomy performed by a herbalist

Ahmet Can ŞENEL, Joanna ONDRUSH

The role of insulin-like growth factor 1 in the development of benign and malignant thyroid nodules

Selahattin VURAL, Metin KEMENT, Dilek YAVUZER, Engin BAŞTÜRK, Hülya GÖZÜ ILIKSU, Ayşe KARADAYI, Cem GEZEN, Mustafa ÖNCEL

Comparison of intravitreal triamcinolone treatment and intravitreal triamcinolone with grid laser treatment in patients with diffuse diabetic macular edema

Hasan Ali TUFAN, Şengül ÖZDEK, Berati HASANREİSOĞLU

General or local anaesthesia in one-day thyroid surgery-Does it matter?

Maya BELİTOVA, Rumen PANDEV, Dimitar KARADIMOV

Late myocardial ischemia induced by a large fistula between left internal mammary graft and left pulmonary vein system

Tuğrul NORGAZ, Sinan DAĞDELEN, Şevket GÖRGÜLÜ

Damage control surgery in the light of a new paradigm: Damage control resuscitation

Mustafa İNAN

Primary percutaneous revascularization using coronary stent in a patient with acute mesenteric ischemia

Ali Soner DEMİR, Soe Moe AUNG, Alaattin ÖZTÜRK

Absence of middle hepatic vein combined with retro-aortic left renal vein: A very rare case report

Sezer AKÇER, Oğuz Aslan ÖZEN, Bumin DEĞİRMENCİ, Ozan TURAMANLAR, Ramazan UYGUR, Oğuz KIRPIKO

Transcatheter aortic valve implantation: Our experience and review of the literature

Ethem KAVUKÇU, Ali ERDOĞAN, Ritvan CHASAN, Nedim SOYDAN, Kamil Mehmet BURGAZLI, Christiane NEUHOF, Mehmet BİLGİN

Effects of luteolin on liver, kidney and brain in pentylentetrazol-induced seizures: Involvement of metalloproteinases and NOS activities

Ayşegül KAPUCU, Gülay ÜZÜM, Kadriye DAR AKGÜN, Samet ACAR, Hüsniye BİRMAN